AbbVie Inc.(ABBV)Stock Forecast 2027 & Price Targets
NYSE

ABBV Stock Forecast Chart

ABBV Stock Forecast 2027: Price Prediction, Price Target & Outlook

Tickzen modelOct 2027 forecast, scaled to the latest close of $289.08

80% of modelled outcomes finish between

$233.00 – $462.58

−19% to +60% from today's $289.08 · 68% chance of finishing above today's price

ABBV Bear Case Forecast 2027

$233.00

−19% vs today

10% probability of finishing below $233.00

ABBV Median Forecast 2027

$328.30

+14% vs today

Midpoint of the range, not a price target

ABBV Bull Case Forecast 2027

$462.58

+60% vs today

10% probability of finishing above $462.58

Short-Term Signal: BullishBased on price above its 50-day average, positive MACD momentum and RSI 65 (strong). View technical factors →
6M + 12M
  • Historical
  • Forecast median
  • 80% range
Tickzen model
ABBV model forecast
Statistical ranges built from price history alone. No analyst opinions in this part.

ABBV Price Probability

Tickzen's model has a median Oct 2027 outcome of $328.30 (+13.6%) for ABBV. Its 80% modelled range is $233.00 to $462.58.

Median outcome
$328.30
+13.6%
Above today
68%
chance of finishing higher
80% range
$233–$463
−19% to +60% vs today
  • Above today’s price68%
    above $289.08
  • Up 10% or more55%
    above $317.99
  • Up 25% or more36%
    above $361.35
  • Up 50% or more15%
    above $433.62
  • Down 10% or more19%
    below $260.17
  • Down 25% or more6%
    below $216.81
  • Down 50% or more<1%
    below $144.54
  • Today $289.08
  • Model median $328.30
  • Analyst mean $282.61
  • 80% range

Hover the curve for the chance of finishing above any price.

These probabilities reflect the model's historical range distribution, not guaranteed returns.

Scenario Analysis Chart

Monthly ABBV Forecast

Tickzen model, prices in US dollars (USD): low, median and high at each month-end (the last row is the final forecast session, about one year out). The range holds 80% of modelled outcomes.

MonthLowMedianHigh
Nov 2026$257$295$338
Dec 2026$252$298$354
Jan 2027$248$301$367
Feb 2027$245$304$378
Mar 2027$242$308$392
Apr 2027$240$311$404
May 2027$238$314$415
Jun 2027$236$318$427
Jul 2027$235$321$439
Aug 2027$234$325$450
Sep 2027$233$328$462
Oct 2027$233$328$463

Model historical accuracy

In historical tests across 300 stocks and 10 start dates, prices finished inside the model's 80% range about 80% of the time across the tested horizons.

80%
3 months
80%
6 months
82%
12 months

See methodology →

Wall Street analysts
ABBV analyst forecast
What the Wall Street analysts covering the stock say. These are opinions, kept separate from the model.

AbbVie Inc. Analyst Consensus & Target Price

Wall Street sentiment and price target analysis for ABBV

BUY

Consensus based on 28 analysts

Buy rating, but the mean price target is below the current price

Mean Target Price
$282.61-2.2%
Median Target$286.50
High Target$328.00
Low Target$200.00
Number of Opinions28

Price Target Analysis

Target Range: $200.00 - $328.00

Current vs Mean Target: -2.2%

Analyst Coverage: 28 firms tracking

What the analysts say

Current30 ratings
3 months ago31 ratings
  • Strong buy 8
  • Buy 16
  • Hold 5
  • Sell 0
  • Strong sell 1

80% of analysts rate it buy or strong buy, up 3 points from 3 months ago.

ABBV analyst actions and price-target changes

Rating moves and price targets published by the firms covering ABBV.

Upgrades / downgrades
2 / 0
last 90 days
Targets raised / cut
15 / 0
last 90 days
Latest median target
$290
17 firms · +0.3% vs today

Price targets since Apr 30, 2026

  • Raised
  • Lowered
  • New target
  • Unchanged
  • Today $289.08

Latest actions

  • UBSTarget raisedOct 9, 2026
    NeutralTarget $275 (from $260, +5.8%)
  • JP MorganTarget raisedOct 8, 2026
    OverweightTarget $300 (from $285, +5.3%)
  • Cantor FitzgeraldTarget raisedOct 8, 2026
    OverweightTarget $290 (from $285, +1.8%)
  • Morgan StanleyTarget raisedOct 7, 2026
    OverweightTarget $310 (from $296, +4.7%)
  • ScotiabankTarget raisedOct 6, 2026
    Sector OutperformTarget $320 (from $280, +14.3%)

ABBV earnings and revenue estimates

What analysts expect the company to report next, and the catalyst that will test it.

Next earnings report

Earnings history →

Oct 30, 2026 in 9 days

EPS estimate
$3.82
Revenue estimate
$17.8B
Options-implied move
±5.6%

Earnings per share

  • Current quarter$3.79$3.61$3.86+104%21
  • Next quarter$3.88$3.77$4.18+43%17
  • Current year$13.96$13.81$14.25+40%27
  • Next year$16.22$15.17$17.65+16%24

Revenue

  • Current quarter$17.4B$17.2B$17.6B+10%20
  • Next quarter$18.3B$18.1B$18.5B+10%16
  • Current year$67.6B$67.2B$68.0B+11%24
  • Next year$73.6B$71.0B$75.0B+9%21

ABBV EPS estimate trend

How the consensus earnings-per-share estimate has moved, and how many analysts raised or cut it.

Current quarter

EPS estimate now

$3.79

−$0.06 (−1.5%) over 90 days

Current quarter EPS estimate now vs earlier
ThenEstimateChange to now
7 days ago$3.80−$0.01 (−0.3%)
30 days ago$3.84−$0.06 (−1.5%)
60 days ago$3.84−$0.06 (−1.5%)
90 days ago$3.85−$0.06 (−1.5%)
Analysts, last 7 days
0 raised · 7 cut
Analysts, last 30 days
0 raised · 8 cut

Next quarter

EPS estimate now

$3.88

−$0.12 (−3.0%) over 90 days

Next quarter EPS estimate now vs earlier
ThenEstimateChange to now
7 days ago$3.87+$0.01 (+0.2%)
30 days ago$3.87+$0.01 (+0.4%)
60 days ago$3.87+$0.02 (+0.4%)
90 days ago$4.00−$0.12 (−3.0%)
Analysts, last 7 days
2 raised · 4 cut
Analysts, last 30 days
2 raised · 5 cut

Current year

EPS estimate now

$13.96

−$0.22 (−1.6%) over 90 days

Current year EPS estimate now vs earlier
ThenEstimateChange to now
7 days ago$13.98−$0.02 (−0.1%)
30 days ago$14.01−$0.05 (−0.4%)
60 days ago$14.01−$0.05 (−0.4%)
90 days ago$14.18−$0.22 (−1.6%)
Analysts, last 7 days
0 raised · 8 cut
Analysts, last 30 days
0 raised · 10 cut

Next year

EPS estimate now

$16.22

−$0.12 (−0.7%) over 90 days

Next year EPS estimate now vs earlier
ThenEstimateChange to now
7 days ago$16.25−$0.04 (−0.2%)
30 days ago$16.27−$0.05 (−0.3%)
60 days ago$16.28−$0.07 (−0.4%)
90 days ago$16.33−$0.12 (−0.7%)
Analysts, last 7 days
2 raised · 5 cut
Analysts, last 30 days
3 raised · 6 cut

Yahoo, as of Oct 19, 2026

ABBV: Tickzen Forecast vs Wall Street Targets

Tickzen's statistical range and the street's published targets on one price axis.

Tickzen median
$328.30
+13.6% vs today
Wall Street mean target
$282.61
−2.2% vs today
Difference
−13.9%
Wall Street below Tickzen
52-week rangewhere it has traded
Low $190.75High $291.33
Model range, Oct 2027Tickzen model, 80% of outcomes
Low $233.00Median $328.30High $462.58
Analyst targetsWall Street, 12-month
Low $200.00Median $286.50Mean $282.61High $328.00

Dashed line: today's price $289.08

The analyst mean target of $282.61 is 13.9% below the model's median of $328.30 for Oct 2027. It sits in the lower half of Tickzen's model range.

The model's Oct 2027 upper range of $462.58 is above ABBV's 52-week high of $291.33, and its lower range of $233.00 is above the 52-week low of $190.75.

They answer different questions: the model's range shows how far ABBV has typically moved, while analyst targets are opinions about what it is worth.

How Tickzen calculates the ABBV forecast range

The range is based on ABBV's own historical price volatility and the model's forecast distribution: 80% of modelled outcomes fall inside it, 10% above and 10% below. The model uses daily price history only; analyst targets are shown separately and are not an input.

Central 80% prediction interval at the end of each period from a lognormal model scaled by the stock's own realised volatility (sqrt-time growth); base is the median path (long-run drift plus a shrunk Prophet trend).

Volatility the model uses
27% a year
blend of the last 6 and 24 months
Volatility, last 30 days
20% a year
latest 20 trading days
Deepest drop
−17.3%
peak to trough, past 2 years
Beta vs S&P 500
0.04
swings less than the market
Market regime
Balanced
Tickzen regime read

The model is a range model, not a price predictor: its centre line is today's price plus normal long-run growth, so the range matters more than any single number. Probabilities describe the model's distribution, not guaranteed returns.

74% of the analyst target range falls inside the model's 80% range.

Model details

  • Model confidence score: 67.8% (High). This is an indicator-agreement score, a heuristic blend of technical indicators, volume, volatility, analyst consensus, data quality and market regime. It is not a probability and has not been back-tested; the validated figures are under Model historical accuracy.
  • Version: tickzen-prophet-v2
  • Anchored to the Oct 2, 2026 close of $262.82
  • Generated Oct 5, 2026
  • Prices are scaled to the latest close: the model is multiplicative around its starting price, so every figure is multiplied by $289.08 / $262.82 = 1.100. The model is refitted on a schedule; the starting price follows the market.
  • Sources: Yahoo Finance prices and analyst data; earnings calendar from Yahoo Finance and Finnhub.